Article Abstract:
The INK4a gene encodes an inhibitor (p16(superINK4a)) of the cyclin D-dependent kinases CDK4 and CDK6 that prevents them from phosphorylating the retinoblastoma protein and obstructs exit from the G1 phase of the cell cycle. The inhibitor negatively affects the growth of the tumors. An unrelated protein (p19(superARF)) arises in major part from an alternative reading frame of the mouse gene. Unitary inheritance of these two proteins signifies their dual requirement in the cell cycle control.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
The function of the acute myeloid leukemia 1 (AML1)-core-binding factor beta heterodimeric trancription factor was studied using mice embryos that were homozygous for the mutation. Homozygous AML1 mutant embryos showed normal erythropoiesis but had defective fetal liver hematopoiesis. Further test which involved disrupting the AML1 allele in embryonic stem cells showed that the stems cells did not undergo hematopoiesis. The AML1 gene was shown to direct hematopoiesis.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
A frequently inactivated tumor suppressor gene in human cancer is INK4a, which encodes p16INK4a, which is a specific inhibitor of CDK4 and CDK6, cyclin D-dependent kinases. The ARF function in mice was selectively disrupted through the deletion of exon 1Beta and leaving all p16INK4a coding sequences. The results indicate that ARF and p53 regulate senescence of mouse embryo fibroblasts.
User Contributions:
Comment about this article or add new information about this topic: